Viewing Study NCT07038993


Ignite Creation Date: 2025-12-25 @ 1:07 AM
Ignite Modification Date: 2026-01-01 @ 7:49 PM
Study NCT ID: NCT07038993
Status: COMPLETED
Last Update Posted: 2025-06-26
First Post: 2025-06-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Venous Pressure Monitoring As a Predictor Of High-Flow Access In Prevalent Hemodialysis Patients
Sponsor: Ain Shams University
Organization:

Study Overview

Official Title: Role of Venous Pressure Monitoring As a Predictor Of High-Flow Access In Prevalent Hemodialysis Patients
Status: COMPLETED
Status Verified Date: 2025-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This study aimed to detect the possibility of using venous pressure as a predictor for high flow access as a simple, non-invasive screening technique in hemodialysis patients.
Detailed Description: The patient's vascular access is often referred to as their "lifeline," and without it, the life-sustaining treatment of hemodialysis would not be possible. To maintain access, patency depends on accurate diagnosis and timely, active interventions.

The Kidney Disease Outcomes Quality Initiative (K/DOQI) recommends native arteriovenous fistula (AVF) as the vascular access of choice for hemodialysis due to its longevity, lower complications, and lower mortality rate compared to catheters.

Currently, K/DOQI guidelines suggest that high intra-access pressure may be regarded as a surrogate for arteriovenous fistula (AVF) outflow stenosis. It can be measured using static venous pressure (sVP) or standardized dynamic venous pressure (dVP).

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: